TransUnion (NYSE:TRU) represented a move of 1.16 percent or $-0.67 per share and closed its previous day trading session at $64.57. 1.57 Million Shares were traded in the last trading session with an Average Volume of 1.47 Million Shares. The stock currently has a Market Capitalization of 11.95 Billion.
TransUnion offers risk and information solutions primarily in the United States and internationally. The Company’s operating segments consists of U.S. Information Services, International and Consumer Interactive. U.S. Information Services segment provides consumer reports, risk scores, analytical services and decisioning capabilities, online data, marketing and decision services. International segment offers online data services, marketing services, credit reports, analytics, decision services, and other value-added risk management services as well as consumer services. Consumer Interactive segment provides solutions including credit reports and scores, credit monitoring, fraud protection and resolution and financial management solutions. TransUnion is headquartered in Chicago, Illinois.
The stock traded between $53.11 and $79.48 over 1-Year time period showing its price to sales ratio of 5.41. TransUnion (NYSE:TRU) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-4.23 and 200-Day Simple Moving Average of $-4.63. Its Price to Free Cash Flow is 33.95 and Price to Book of 6.4.
Analyst’s recommended the stock as 1.8 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, TransUnion (NYSE:TRU) reported its Actual EPS of $0.65/share. The analysts offering Earnings Estimates for the company were believing that TransUnion could bring EPS of $0.62/share. The difference between Actual EPS and Estimated EPS was 0.03 Percent. Thus showing an Earnings Surprise of 4.8 Percent.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
In the last trading session, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) added its value by 0.08% closing at the price of $36.82. The stock currently has market capitalization of 2.11 Billion, with average volume of 2.92 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is showing beta of 0.52. This particular value of beta suggests that Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has historically moved 52% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is at $-10.37.
The stock currently has RSI of 55.43. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Tandem Diabetes Care, Inc. is a medical device company. The Company designs, develops, and commercializes products for people with insulin-dependent diabetes. Its products include t:slim Insulin Delivery System. Tandem Diabetes Care, Inc. is headquartered in San Diego, California.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) topped its 52-week high price of $52.55 on 09/13/18 and 52-Week Low Price of $ 2.14 on 02/09/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 6.41% and monthly volatility of 9.36% respectively.